Bioorganic and Medicinal Chemistry Letters p. 2069 - 2072 (1996)
Update date:2022-08-05
Topics:
Kirkup, Michael P.
Rizvi, Razia
Shankar, Bandarpalle B.
Dugar, Sundeep
Clader, John W.
McCombie, Stuart W.
Lin, Sue-Ing
Yumibe, Nathan
Huie, Keith
Van Heek, Margaret
Compton, Douglas S.
Davis Jr., Harry R.
McPhail, Andrew T.
Previous SAR studies of C-3 side chain modified analogs of (-)-SCH 48461, as well as information concerning the metabolic stability this series, enabled us to design a cholesterol absorption inhibitor (i.e., (-) 2a, SCH 57939) with tenfold higher potency and greatly enhanced metabolic stability. The synthesis and pharmacological profile, including the role of relative stereochemistry at both the C3 and 1' positions in determining the SAR of these compounds, will be discussed.
View MoreChangde Yungang Biotechnology Co., Ltd
website:http://www.cdyg.com
Contact:+86-736-7391178
Address:Qiaonan Industrial Park, Changde City, Hunan Province
Hangzhou Haiqiang Chemical Co.,Ltd.
Contact:+86-571-86960370
Address:Add: 5/F, Around Town North Road,No. 10, Hangzhou, Zhejiang,China
Shanghai Taibao Pharmaceutical Technology Co., Ltd(expird)
Contact:021-52217366
Address:shanghai
Shenzhen HwaGen Pharmaceutical Co., Ltd
website:http://www.rafflespt.com
Contact:+86-752-5538396
Address:Guangdong Huizhou China
Shanghai Send Pharmaceutical Technology Co., Ltd.
website:http://www.shsendpharma.com
Contact:021-58088081, +8613585868794
Address::Room A601, Building 1,NO. 800 Qingdai Road Pudong District Shanghai,China
Doi:10.1002/psc.3148
(2019)Doi:10.1080/00945719809351659
(1998)Doi:10.1021/ja01006a029
(1968)Doi:10.1007/s11426-015-5368-z
(2015)Doi:10.1016/S0040-4039(02)02150-0
(2002)Doi:10.1016/j.bmcl.2005.09.004
(2006)
